Footnotes : S.C. DHEC newborn screening newsletter by South Carolina Department of Health and Environmental Control
OUR BEST FOOT FORWARD
September is National Newborn Screening Awareness 
Month!!! 
Did you know that most states follow the Recommended Uniform 
Screening Panel (RUSP) when adding new conditions to their panel? 
South Carolina is currently screening for 31 of the 34 recommended 
conditions with plans to add 3 new conditions in the near future. 
The committee that works to set national guidelines is called the 
Advisory Committee on Heritable Disorders in Newborns and 
Children (ACHDNC). The committee meets regularly to discuss 
proposals from parent advocates, organizations and medical experts 
in order to keep newborn screening up to date. In addition, the 
secretary of the U.S. Department of Health and Human Services 
reviews the committee’s recommendations. The committee and 
the Secretary work together to create the RUSP. The RUSP is a list 
of conditions, including 34 core conditions that the committee 
recommends every baby should be screened for. The RUSP 
recommendation is not a law or mandate, but it serves as a helpful 
guide for the states. Visit the committee’s website at www.hrsa.gov/
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ON THE SPOT
The hospitals listed below had 0% 
unsatisfactory specimens for the 
first half of 2018:
• Georgetown Memorial Hospital
• McLeod Health Cheraw
• McLeod Health Clarendon
NBS Collection Training Opportunity:
We have had great participation for 2018 newborn screening 
dried blood spot collection training!
Upstate: 24 participants 
Public Health Lab: 22 participants
Pee Dee: 27 participants
There are two more opportunities in 2018 to attend a training 
workshop. We hope you are able to participate. 
Midlands: August 17, 2018
Lowcountry: November 08, 2018
Please email nbscollectiontraining@dhec.sc.gov to register for 
an upcoming training.
Updates in Screening for Cystic Fibrosis: 
Disorder Summary: 
The SC newborn screening laboratory screens dried blood spots to 
identify newborns with an increased risk for Cystic Fibrosis (CF). Cystic 
Fibrosis is an inherited disorder affecting the pulmonary, digestive 
and reproductive systems. CF causes an excessive production of 
abnormally thick and sticky mucus. If left untreated, CF can lead to 
malnutrition, hypoxia and premature death. Due to advancements 
in newborn screening, public health laboratories are able to perform 
screening measuring immunoreactive trypsinogen (IRT), the primary 
screening marker for CF. When an abnormal or elevated IRT value 
is yielded, a repeat specimen is requested to allow for a second 
analysis of the IRT level. This two-step testing is referred to as 
the IRT/IRT protocol. These patients are referred to their nearest 
Cystic Fibrosis Foundation-accredited care center to pursue further 
diagnostic testing.
Updated Lab Method:  
In an attempt to decrease the number of false positive CF screening 
results, the laboratory is bringing on a qualitative genotyping (DNA 
analysis) test to detect a panel of approximately 60 mutations and 
variants in the CF transmembrane conductance regulator (CFTR) 
gene. The panel represents the most frequently identified mutations 
found in CF patients. This will enable the laboratory to transition 
from an IRT/IRT protocol to an IRT/DNA protocol. In the IRT/DNA 
protocol, an initial specimen that yields an abnormally high IRT result 
will be reflexed for DNA analysis on the initial specimen, thereby 
reducing the need for repeat specimens for CF screening.  
Next Steps: Validation of the IRT/DNA protocol in the laboratory 
has been completed. A recorded webinar will be held on August 15 
to discuss the test and change in testing algorithm. Administrative 
requirements must be completed to add the new protocol into the 
NBS laboratory and follow-up workflows. More information for the 
newborn screening healthcare community and news of the start 
of the pilot study for preliminary screening for CF by the IRT/DNA 
protocol is forthcoming. We anticipate the pilot study to start the first 
week of September.
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CONTACT US. WE’RE HERE TO HELP!
DHEC Newborn Screening Follow Up:  
(803) 898-0593 or (803) 898-1969
Public Health Laboratory: (803) 896-0891
Keep us on our toes. Please give us feedback on what 
you would like to see in our next Footnotes Edition. Email 
newbornscreening@dhec.sc.gov with your suggestions.
ON THE RUN
Sickle Cell Results for NCAA
September is Sickle Cell Awareness Month. If you are in  
need of a patient’s sickle cell results for NCAA requirements 
please fax a request including the patient’s name, date of  
birth and mother’s name at the time of the patient’s birth to  
803-896-0889 or call 803-896-0795. 
 Lab Closings for the remainder of 2018: 
• Monday, Sept. 3, 2018: 
Labor Day
• Saturday, Nov. 10, 2018:  
Veterans Day Observance
• Thursday, Nov. 22, 2018:  
Thanksgiving
• Friday, Nov. 23, 2018:  
Thanksgiving
• Tuesday, Dec. 25, 2018:  
Christmas 
• Wednesday, Dec. 26, 2018:  
Christmas
• Tuesday, Jan. 1, 2019:  
New Year’s
How do I fill out the demographic  
information on the filter paper when an infant  
is being adopted? 
The baby’s name field on the newborn screening filter paper 
form should reflect the infant’s legal name at the time of 
birth or adopted name (if known). If the infant’s name is 
unknown at the time of collection, enter the infant’s name as 
mother’s last name, first name “Adoption.” (Example: “Smith, 
Adoption”)
If the birth mother is not to be contacted, please enter the 
lawyer’s first and last name or adoption agency’s name in 
the mother’s name fields as the legal guardian. In the street 
address field, enter the lawyer or adoption agency’s address 
as the legal guardian contact. Also, enter the phone number 
of the lawyer or adoption agency in lieu of the birth mother’s 
phone number. 
When known, always enter the physician’s demographics and 
infant’s medical record number in entirety. This will assist the 
Newborn Screening Program in locating an infant if there is a 
need to alert the lawyer/legal guardian or adoption agency of 
an abnormal or potentially life-threatening result and ensure 
the infant gets the medical attention she or he needs.
EDUCATIONAL 
INFORMATION: 
Are you educating your parents 
about Newborn Screening? Visit 
our website at www.scdhec.gov/
newbornmetabolicscreening 
to find our newborn screening 
brochure and educational 
handouts for parents and 
providers.
Are you in need of NBS brochures?
Please go to www.scdhec.gov/Agency/EML/place_order.aspx. 
Using the ML number search, you can order the brochure in 
English (ML-000032) or Spanish (ML-025096).
Medium chain acyl co-A dehydrogenase 
deficiency (MCADD)
This fatty acid disorder causes the baby’s body 
to be unable to use certain kinds of fat to make 
energy. Babies with MCADD may get very sick 
if they are ill and cannot eat like usual. They 
can have trouble breathing and have seizures. 
Their hearts may even stop beating. To treat 
this disorder, baby must eat every few hours 
and receive fast medical care when sick.
Less common fatty acid disorders:
• Medium chain ketoacyl coA thiolase 
deficiency
• Short chain acyl coA dehydrogenase 
deficiency
• Medium and short chain 3-OH acyl coA 
dehydrogenase deficiency
• Dieonyl coA reductase deficiency
• Long chain 3-OH acyl coA dehydrogenase 
deficiency
• Trifunctional protein deficiency
• Very long chain acyl coA dehydrogenase 
deficiency
• Glutaric aciduria II
• Carnitine uptake/transport deficiency
• Carnitine palmitoyltransferase I deficency
• Carnitine palmitoyltransferase II deficiency
• Carnitine/acylcarnitine translocase 
deficiency
To treat these disorders, baby may receive a 
special diet and medicine.
Hormone and Enzyme Disorders
Congenital hypothyroidism
In this disorder, the thyroid gland does not 
work properly. Baby does not grow or function 
normally and may develop severe intellectual 
disability. To treat this disorder, babies take a 
special medicine.
Congenital adrenal hyperplasia (CAH)
In this disorder, the body’s adrenal glands do 
not work normally. Babies with CAH will not 
grow or mature the right way. Some of these 
babies may even die. A baby with CAH can be 
treated with medicine.
Biotinidase deficiency
In this disorder, baby’s body cannot use biotin, 
a vitamin in food. Without biotin, babies 
cannot grow and develop the right way. To 
treat this disorder, baby must take a special 
form of biotin in a capsule or tablet.
Genetic Disorders
Hemoglobinopathies & hemoglobinopathy traits
Hemoglobinopathies are blood disorders. They 
can cause misshaped red blood cells, anemia, 
severe pain and high risk for infections. 
Sometimes medicines are used to treat these 
disorders. 
Sickle Cell Disease 
This disorder is a hemoglobinopathy. It causes 
sickle-shaped red blood cells, anemia, and 
other health problems. Medicine is used 
to treat this disease. Babies with sickle cell 
disease need to see a specialist.
Sickle Cell Trait
A baby with Sickle Cell Trait has one gene 
that makes sickle-shaped red blood cells and 
one gene that makes normal red blood cells. 
Persons with sickle cell trait are usually not 
sick but can have kidney problems as they 
get older. They should get genetic counseling 
about sickle cell trait. Seeing a doctor for 
checkups every year is important too. 
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Cystic fibrosis
This disorder causes severe lung and digestive 
problems due to thick and sticky body fluids. 
Babies can have serious infections in their 
lungs and cannot digest their food well. To 
treat this disorder, babies take medicine to 
help fight infections and enzymes to help 
digest food.
Severe Combined Immunodeficiency
Severe Combined Immunodeficiency (SCID) 
and related disorders involve the immune 
system. Babies with SCID are not able to fight 
infection due to malfunction of their immune 
system. Although babies with SCID can appear 
healthy at birth, they can become sick very 
quickly from common illnesses like a cold or 
stomach virus. Some babies with SCID need 
a bone marrow transplant while less severe 
forms of these disorders can be treated with 
special medicines.
What happens to my baby’s blood 
sample after the lab tests it?
DHEC will destroy your baby’s blood sample 
once it is no longer needed for testing. It 
will not be used for any purpose other than 
newborn screening.  If you have questions 
about how your baby’s blood sample is 
handled, call the Newborn Screening Follow-
up Program, at (803) 898-0767 or the Public 
Health Laboratory at (803) 896-0800.
What else can I do to care for my baby?
Make sure your baby gets well baby checkups. 
Along with newborn screening, checkups help 
you make sure that your baby is healthy and 
that problems are found before they become 
serious.
For more information, contact: 
• SC DHEC
 Newborn Screening Program
 2100 Bull Street
 Columbia SC 29201
• Your county public health department
Newborn 
Screening
For Your Baby’s HealthNote: There are other metabolism disorders that
cannot be found through newborn screening.
Note: There are other hormone and enzyme
disorders that cannot be found through newborn
screening.
Note: There are other genetic disorders that

























































































¿Qué sucede con la muestra de sangre de mi 




































Meeting announcement: Updates to the DHEC 
regulation for newborn screening
There will be a stakeholder meeting on August 22, 2018 at 
11:30 a.m. in the Mills Jarrett Building, Room N200 (2100 Bull 
St, Columbia, SC 29201) to discuss proposed updates to South 
Carolina Code of Regulation 61-80 for newborn screening. For more 
information, contact Dr. Brent Dixon at dixonrb@dhec.sc.gov. 
To view the South Carolina Code of Regulation 61-80 for newborn 
screening please visit https://www.scstatehouse.gov/coderegs/
Chapter%2061-80%20through%2061-92.pdf.
